Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
BioDelivery Sciences Internati (NQ: BDSI)
4.660 USD  +0.220 (+4.95%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Blog posts about BioDelivery Sciences Internati
 
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Long Term Investor Alert: Investigation
March 05, 2013
San Diego, CA -- (SBWIRE) -- 03/05/2013 -- An investigation on behalf of current long-term investors of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shares over potential breaches of... Read More
from SBWire - Latest Press Releases
(CHTP) Chelsea Therapeutics International Shows Encouraging News
March 01, 2013
Chelsea Therapeutics International Ltd. (CHTP) recently announced that it received written guidance... Visit StockBlogHub to view complete post. Read More
category Biotechnology , TEVA , Charles River Laboratories International Inc , and 7 more.
from Stock Blog Hub
Hot Biotech. Stocks: BioDelivery Sciences International, Arena Pharmaceuticals, Onyx Pharmaceuticals, Heska Corp
March 01, 2013
Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Hot Biotech. Stocks: BioDelivery Sciences International, CytRx Corporation, Corcept Therapeutics Incorporated, Heska Corp
February 27, 2013
Lakeway, TX -- (SBWIRE) -- 02/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
SmallCapNewsRelease: Oculus (NASDAQ: OCLS) Reduces Expenses $2.5 Million for Q4
September 20, 2012
Jericho, NY -- (SBWIRE) -- 09/20/2012 -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) a commercial healthcare company that designs, produces and markets safe and effective healthcare products... Read More
from SBWire - Latest Press Releases
PennyStocks101.com Reports 3 Stocks With New 52-week Highs on Thursday - Apple Inc., Biodelivery Sciences, and Comcast Corp.
September 13, 2012
Huntington Beach, CA -- (SBWIRE) -- 09/13/2012 -- www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout... Read More
from SBWire - Latest Press Releases
Biggest Gainning Stocks Are Costing Your Business Money (BDSI, LNCE, IMUC,ENMD)
September 07, 2012
Los Angelas, CA -- (SBWIRE) -- 09/07/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
(BDSI) BioDelivery Sciences International Shows Pipeline Progress
August 26, 2012
BioDelivery Sciences International Inc. (BDSI) recently announced that it has finished enrolling... Visit StockBlogHub to view complete post. Read More
category Biotechnology , BNX , Banks/com Inc , and 5 more.
from Stock Blog Hub
New Analyst Coverage
July 03, 2012
New York, July 3rd (TradersHuddle.com) – Following are some of the new analyst ratings before the market open. Research Firms Initiate: Amercian National Bankshar. Read More -- Read More
from TradersHuddle.com
Endo Pharma To Shell Out $15M
April 18, 2012
Following the decision of the US patent and trademark office to extend the patent protection of BioDelivery Sciences International’s (NASDAQ:BDSI) pain candidate BEMA buprenorphine by seven years to... Read More
category ENDP , BDSI , Stocks , and 2 more.
from DailyMarkets.com
BDSI, LNG, MIPS, SSYS Among Charts to Watch
April 18, 2012
It was a great day for the stock market on Tuesday, and there were quite a few movers. It went right up to key overhead resistance, and backed off a little. We’ll have to see whether it can reach... Read More
from Charts of the Day by Harry Boxer
Management Change At Endo Pharma
March 30, 2012
Endo Pharmaceuticals Holdings Inc. (NASDAQ:ENDP) recently announced a change in its management team. The company announced that Mr. Tony Bihl, the man at the helm of Endo devices operating company (a... Read More
category ENDP , BDSI , Stocks , and 3 more.
from DailyMarkets.com
Endo Pharma Treads The Neutral Path
March 16, 2012
We are maintaining our Neutral stance on Endo Pharmaceuticals (NASDAQ:ENDP) with a target price of $38.00. Endo Pharma is a specialty healthcare solutions company that operates in the US and focuses on... Read More
category ENDP , BDSI , WPI , and 4 more.
from DailyMarkets.com
Apple, Nasdaq, Lead in Mixed Session
January 06, 2012
The stock market indices moved down early, and then rallied midday, but at the end of the day dipped into negative territory on the blue chips, although the Nasdaq 100 was up today, with Apple Inc.... Read More
from Harry's Hotline by Harry Boxer
Top Biotech Movers (VICL, BDSI, TNGN, DNDN, REGN)
January 06, 2012
New York, January 6th (TradersHuddle.com) – Vical Incorporated ( NASDAQ: VICL ) plunged 12.15% to $3.76 in the morning trading after the company announced the pricing of an underwritten public offering... Read More
from TradersHuddle.com
Standard and Poor’s Worst Mistake Yet
August 08, 2011
category Week/Ahead , Rating/Agencies , Editors/Picks , and 1 more.
from Wall Street Greek
(CEPH) Cephalon Second Quarter 2010 Earnings Report Beats The Street
July 28, 2010
Cephalon Inc. (CEPH) delivered another strong quarter with second quarter earnings coming in at $2.05 per share, six cents above the Zacks Consensus Estimate and well above the year-ago earnings of... Read More
category Watson Pharmaceuticals Inc/ , TEVA , Cephalon Inc/ , and 11 more.
from Stock Blog Hub
(CEPH) Cephalon’s Quarterly Earnings Report Beats – Updates Guidance
May 05, 2010
Cephalon, Inc. (CEPH) started 2010 on a strong note with first quarter earnings beating expectations by a wide margin. The company reported first quarter earnings of $1.76 per share, 20 cents above the... Read More
category Watson Pharmaceuticals Inc/ , TEVA , Cephalon Inc/ , and 9 more.
from Stock Blog Hub
The Luck of the Irish Strikes DC
March 17, 2010
from Wall Street Greek
(CEPH) Cephalon Earnings Estimates Up on Company Guidance
March 16, 2010
Earnings estimates for Cephalon, Inc. (CEPH) have gone up significantly following the issuance of a better-than-expected guidance by the company. Cephalon exited 2009 on a strong note with both... Read More
category Watson Pharmaceuticals Inc/ , TEVA , Cephalon Inc/ , and 9 more.
from Stock Blog Hub
China - Iran and Fair Trade
March 15, 2010
from Wall Street Greek
(CEPH) Cephalon Beats Earnings Expectations and Guides Higher
February 12, 2010
Cephalon, Inc. (CEPH) exited 2009 on a strong note with both fourth quarter and full year earnings exceeding expectations. The company reported fourth quarter earnings of $1.66 per share, 6 cents above... Read More
category Watson Pharmaceuticals Inc/ , TEVA , Cephalon Inc/ , and 9 more.
from Stock Blog Hub
BioDelivery Sciences International Inc. (BDSI, rated BUY)
December 25, 2009
Analysts' Targets Robert W. Baird & Co. $7 Outperform Wednesday, August 19, 2009 Roth Capital Partners $7 Buy Wednesday, July 29, 2009 BDSI Market Data Currency US Dollars Share Price $4.01 Change... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
(CEPH) Cephalon Settles Barr Pharmaceuticals Challenge
November 26, 2009
Earlier this month, Cephalon Inc. (CEPH) announced that it has settled its patent infringement case with Barr Pharmaceuticals, which is now owned by Teva Pharmaceutical (TEVA). Barr was looking to... Read More
category Watson Pharmaceuticals Inc/ , TEVA , Cephalon Inc/ , and 7 more.
from Stock Blog Hub
($CEPH) Cephalon Beats Forecasts – Provides Outlook
October 28, 2009
Cephalon Inc. (CEPH) reported strong third-quarter earnings of $1.62 per share that easily surpassed the Zacks Consensus Estimate of $1.42 per share and the year ago earnings of $1.18. Revenues... Read More
category TEVA , Cephalon Inc/ , CNS , and 7 more.
from Stock Blog Hub
BioDelivery Sciences (NASDAQ: BDSI): Restarting the Catalyst Cycle (BDSI, rated BUY)
October 15, 2009
BioDelivery Sciences (NASDAQ: BDSI) is a specialty pharmaceutical company that develops new indications for approved drug compounds by applying its proprietary drug delivery technology platform, BEMA... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
FDA Calendar Updates: Still Waiting on BDSI (BDSI, rated BUY)
July 14, 2009
Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 258 entries as of 7/14/09. The calendar was originally created by Mike Havrilla to... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
20 Extreme Trades on Pending FDA Decisions (BDSI, rated BUY)
June 21, 2009
Below are 20 extreme trades among companies with market caps under $500 million from the <font> BioMedReports.com FDA Calendar </font> (database includes 225 entries as of 6/21/09) which have pending... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
FDA Calendar Updates: BDSI, SVNT Deadlines Approach (BDSI, rated BUY)
June 11, 2009
Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
(BDSI) FDA decision Friday June 12, 2009 (BDSI, rated BUY)
June 10, 2009
BDSI is awaiting a June 15, 2009 FDA decision date on its Onsolis breakthrough cancer pain drug. Onsolis is a fast-dissolving film applied to the lining of the mouth that delivers the potent painkiller... Read More
category Healthcare , Biotechnology & Drugs
from SocialPicks.com: Front Page Picks
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here